При изпитвания за канцерогенен ефект на перорален рисперидон при плъхове и мишки
In oral carcinogenicity studies of risperidone in rats and mice, increases in pituitary gland adenomas (mouse), endocrine pancreas adenomas (rat), and mammary gland adenomas (both species) were seen.